Assignee
SHANGHAI ARK BIOPHARMACEUTICAL CO LTD
CN·1 granted patent·3 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
4 records- 0156US2025215020A1Compounds as elastase inhibitor and method of preparing the sameSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0255US2025213598A1Compounds as elastase inhibitor and solid form thereofSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0342US2022387443A1Respiratory syncytial virus fusion protein inhibitor compositions and methods for the treatment and prophylaxis of rsv diseases using the sameSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0441US12582661B2Synthesis and application of class of respiratory syncytial virus inhibitorsSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 24, 2026·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI ARK BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →